ProCE Banner Series

Advances in Systemic Mastocytosis: Getting to the Root of Disease With New and Emerging Targeted Treatments

Join expert faculty to master the best practices in recognizing and diagnosing systemic mastocytosis. Discover the latest advancements in targeted therapeutics, opening new avenues to enhance patient outcomes and quality of life.

  AAPA
  | AMA
  | ANCC
Who Should Attend

This program is intended for US-based physicians, including residents and fellows; physician associates; and nurse practitioners practicing in allergy/immunology, dermatology, and other nononcology specialties who care for patients with systemic mastocytosis.

All Events

Advances in Systemic Mastocytosis: Getting to the Root of Disease With New and Emerging Targeted Treatments

Upcoming Events

January

22

2025

8:00 PM - 9:00 PM Eastern Time (ET)

Virtual

Past Events

November

26

2024

6:30 PM - 7:30 PM Eastern Time (ET)

Virtual

Faculty

ProCE Banner Faculty
Cem Akin, MD, PhD

Professor of Medicine
Division of Allergy and Immunology
Department of Internal Medicine
University of Michigan
Ann Arbor, Michigan

ProCE Banner Faculty
Matthew Giannetti, MD

Division of Allergy and Clinical Immunology
Brigham and Women’s Hospital
Boston, Massachusetts

Topics

Systemic Mastocytosis

Additional Info

There are no fees required to participate in this activity.

Americans With Disabilities Act 
Event staff will be glad to assist you with any special needs (eg, physical, dietary). Please contact customer support prior to the live event.

CME/CE Info

Goal Statement
The goal of this program is to improve the knowledge, competence, and performance of learners in diagnosing and managing systemic mastocytosis so that patients will experience improvements in symptoms and quality of life and reduced disease progression.

Target Audience
This program is intended for US-based physicians, including residents and fellows; physician associates; and nurse practitioners practicing in allergy/immunology, dermatology, and other nononcology specialties who care for patients with systemic mastocytosis. 

Learning Objectives
Upon completion of this event, participants should be able to:

  • Incorporate SM into the differential diagnoses of patients presenting with heterogeneous symptoms indicative of the disease
  • Apply recommended criteria to the diagnosis and subtyping of SM
  • Identify patient candidates for new and emerging targeted therapies for SM

Accreditation

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. 

Physician Continuing Medical Education

CCO designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Professional Development

The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 1.0 contact hour.

Physician Associate Continuing Medical Education

Clinical Care Options, LLC has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credit. PAs should only claim commensurate with the extent of their participation.

American Board of Internal Medicine Maintenance of Certification 

A blue and black sign with white textDescription automatically generated

Successful completion of this CME activity, which included participation in the evaluation component, enables the participant to earn up to 1.0 MOC point in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

For ABIM MOC points, your information will be shared with the ABIM through CCO's Joint Accreditation Program and Activity Reporting System (JAPARS). Please allow 6-8 weeks for your MOC points to appear on your ABIM records.

By sharing your Diplomate Board ID # and DOB, you are giving Clinical Care Options, LLC permission to use this information/data to report your participation to these Boards via the Joint Accreditation Program and Activity Reporting System (JA-PARS).

CME Passport

A logo for a companyDescription automatically generated

The CME credits that physicians earn from this activity will be submitted to ACCME's CME Passport, a free, centralized web application where you can create a personalized account to view, track, and generate transcripts of your reported CME credit. Visit www.cmepassport.org to create your account.

Disclosure of Conflicts of Interest
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

Acknowledgement

Provided by Clinical Care Options, LLC.

Supported by an educational grant from Blueprint Medicines Corporation.